Clearmind Medicine partners with Polyrizon for intranasal MEAI formulation

Go back to Clearmind Medicine partners with Polyrizon for intranasal MEAI formulation
(NASDAQ: CMND) Delayed: 3.46 +0.12 (3.59%)
Previous Close $3.34    52 Week High
Open $3.28    52 Week Low
Day High $3.55    P/E N/A 
Day Low $3.26    EPS
Volume 71,171       

(NASDAQ: PLRZ) Delayed: 11.71 +0.13 (1.12%)
Previous Close $11.58    52 Week High
Open $11.84    52 Week Low
Day High $12.60    P/E N/A 
Day Low $11.71    EPS
Volume 11,846